Barclays’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-409
| Closed | -$8K | – | 4679 |
|
|
2024
Q4 | $8K | Hold |
409
| – | – | ﹤0.01% | 4209 |
|
|
2024
Q3 | $6K | Hold |
409
| – | – | ﹤0.01% | 4185 |
|
|
2024
Q2 | $3K | Hold |
409
| – | – | ﹤0.01% | 4081 |
|
|
2024
Q1 | $6K | Hold |
409
| – | – | ﹤0.01% | 4052 |
|
|
2023
Q4 | $6K | Hold |
409
| – | – | ﹤0.01% | 4080 |
|
|
2023
Q3 | $5K | Hold |
409
| – | – | ﹤0.01% | 4119 |
|
|
2023
Q2 | $10K | Sell |
409
-960
| -70% | -$23.5K | ﹤0.01% | 4058 |
|
|
2023
Q1 | $50K | Buy |
1,369
+454
| +50% | +$16.6K | ﹤0.01% | 3791 |
|
|
2022
Q4 | $56K | Buy |
915
+427
| +88% | +$26.1K | ﹤0.01% | 3742 |
|
|
2022
Q3 | $37K | Sell |
488
-15
| -3% | -$1.14K | ﹤0.01% | 3747 |
|
|
2022
Q2 | $58K | Sell |
503
-25
| -5% | -$2.88K | ﹤0.01% | 3676 |
|
|
2022
Q1 | $100K | Buy |
+528
| New | +$100K | ﹤0.01% | 3664 |
|